Study Reveals How Listeria Breaches the Placenta

Article

A gut bacterium called Listeria (Listeria monocytogenes), which is often found in soft cheese, is known to present a risk to pregnant women. Listeria uses distinct tactics to breach the intestine and the placenta, using a protein called phosphoinositide-3 kinase (PI3-K), according to a study published in the Journal of Experimental Medicine.

Listeria has two proteins that help it cross mucosal tissue barriers. Both proteins, called internalins A and B, attach to tissue receptors and are needed for Listeria to invade the placenta, but protein A alone can propel Listeria across the intestine. What underlies these differences has remained unknown.

Tissue invasion by Listeria also requires the enzyme PI3-K. This enzyme is turned on by both of the Listeria’s internalin proteins, but only the B protein has a built-in activation mechanism. Lecuit and colleagues at the Pasteur Institute in France have been able to visualize the activation of PI3-K, finding that this enzyme is very important for Listeria invasiveness via internalins. They uncover that PI3-K is perpetually turned on in intestinal cells, using only internalin A and rendering internalin B dispensable. The placenta, by contrast, has little to no inherent PI3-K activity, which is why passage of the bug through the placenta requires both A and B internalins.

These findings open up exciting new opportunities to examine whether other microbes-in addition to those posing a pregnancy risk-are capable of crossing host barriers using PI3-K activation, and whether this mechanism of bug invasion also occurs in other mucosal tissues and organs.

Reference: Gessain G., et al. 2015. J. Exp. Med. doi:10.1084/jem.20141406

Source: The Rockefeller University Press 

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content